|A culture positive case of Streptococcal pharyngitis with typical tonsillar exudate|
|Symptoms||Sore throat, fever, enlargement of the tonsils, trouble swallowing, large lymph nodes around the neck|
|Duration||~ 1 week|
|Causes||Viral infection, bacterial infection|
|Diagnostic method||Based on symptoms, throat swab, rapid strep test|
|Medication||Paracetamol (acetaminophen), ibuprofen, penicillin|
|Frequency||7.5% (in any given 3 months)|
Tonsillitis is inflammation of the tonsils, typically of rapid onset. It is a type of pharyngitis. Symptoms may include sore throat, fever, enlargement of the tonsils, trouble swallowing, and large lymph nodes around the neck. Complications include peritonsillar abscess.
Tonsillitis is most commonly caused by a viral infection, with about 5% to 40% of cases caused by a bacterial infection. When caused by the bacterium group A streptococcus, it is referred to as strep throat. Rarely bacteria such as Neisseria gonorrhoeae, Corynebacterium diphtheriae, or Haemophilus influenzae may be the cause. Typically the infection is spread between people through the air. A scoring system, such as the Centor score, may help separate possible causes. Confirmation may be by a throat swab or rapid strep test.
Treatment efforts involve improving symptoms and decreasing complications. Paracetamol (acetaminophen) and ibuprofen may be used to help with pain. If strep throat is present the antibiotic penicillin by mouth is generally recommended. In those who are allergic to penicillin, cephalosporins or macrolides may be used. In children with frequent episodes of tonsillitis, tonsillectomy modestly decreases the risk of future episodes.
About 7.5% of people have a sore throat in any three-month period and 2% of people visit a doctor for tonsillitis each year. It is most common in school aged children and typically occurs in the fall and winter months. The majority of people recover with or without medication. In 40% of people, symptoms resolve within three days, and in 80% symptoms resolve within one week, regardless of whether streptococcus is present or not. Antibiotics decrease symptom duration by approximately 16 hours.
Signs and symptoms
- sore throat
- red, swollen tonsils
- pain when swallowing
- high temperature (fever)
- a general sense of feeling unwell (malaise)
- white pus-filled spots on the tonsils
- swollen lymph nodes (glands) in the neck
- pain in the ears or neck
- weight loss
- difficulty ingesting and swallowing meal/liquid intake
- difficulty sleeping
Less common symptoms include:
- stomach ache
- furry tongue
- bad breath (halitosis)
- voice changes
- difficulty opening the mouth (trismus)
- loss of appetite
- anxiety/fear of choking
In cases of acute tonsillitis, the surface of the tonsil may be bright red and with visible white areas or streaks of pus.
The most common cause is viral infection. It accounts for 50 to 80% of tonsillitis cases. It most often includes adenovirus, rhinovirus, influenza, parainfluenza, coronavirus, and respiratory syncytial virus. It is occasionally caused by Epstein-Barr virus, herpes simplex virus, cytomegalovirus, or HIV. About 1 to 10% of the cases are caused by Epstein-Barr virus.
The second most common cause is bacterial infection of which the predominant is Group A β-hemolytic streptococcus (GABHS), which causes strep throat. Bacterial infection of the tonsils usually follows the initial viral infection. Less common bacterial causes include: Staphylococcus aureus (including methicillin resistant Staphylococcus aureus or MRSA ), Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Bordetella pertussis, Fusobacterium sp., Corynebacterium diphtheriae, Treponema pallidum, and Neisseria gonorrhoeae.
Under normal circumstances, as viruses and bacteria enter the body through the nose and mouth, they are filtered in the tonsils. Within the tonsils, white blood cells of the immune system destroy the viruses or bacteria by producing inflammatory cytokines like phospholipase A2, which also lead to fever. The infection may also be present in the throat and surrounding areas, causing inflammation of the pharynx.
In primary care settings (health clinics), Centor criteria is used to determine the likelihood of group A beta-hemolytic streptococcus (GABHS) infection in an acute tonsilitis and the need of antibiotics for tonsilitis treatment. However, Centor criteria has its weaknesses in making precise diagnosis for adults. Besides, it is also ineffective in diagnosis for tonsilitis in children and in secondary care settings (hospitals). There are four major criteria in Centor score: presence of tonsillar exudate, painful neck lymph nodes, history of fever, age between 5 and 15 years, and the absence of cough. The possibility of GABHS infection increases with increasing score. The probability for getting GABHS is 2 to 23% for the score of 1, and 25 to 85% for the score of 4.
The diagnosis of GABHS tonsillitis can be confirmed by culture of samples obtained by swabbing the throat and plating them on sheep blood agar medium. The isolation rate can be increased by incubating the cultures under anaerobic conditions and using selective growth media. A single throat culture has a sensitivity of 90–95% for the detection of GABHS (which means that GABHS is actually present 5–10% of the time when the culture result suggests that it is absent). This small percentage of false-negative results are part of the characteristics of the tests used but are also possible if the patient has received antibiotics prior to testing. Identification requires 24 to 48 hours by culture but rapid screening tests (10–60 minutes), which have a sensitivity of 85–90%, are available. True infection with GABHS, rather than colonization, is defined arbitrarily as the presence of >10 colonies of GABHS per blood agar plate. However, this method is difficult to implement because of the overlap between carriers and infected patients. In 40% of the people without any symptoms, the throat culture can be positive. Therefore, throat culture is not routinely used in clinical practice for the detection of GABHs.
Older antigen tests detect the surface Lancefield group A carbohydrate. Newer tests identify GABHS serotypes using nucleic acid (DNA) probes or polymerase chain reaction. Bacterial culture may need to be performed in cases of a negative rapid streptococcal test. An increase in antistreptolysin O (ASO) streptococcal antibody titer 3–6 weeks following the acute infection can provide retrospective evidence of GABHS infection and is considered definitive proof of GABHS infection.
Epstein Barr virus serology can be tested for those who may have infectious mononucleosis with a typical lymphocyte count in full blood count result. Blood investigations are only required for those with hospital admission and required intravenous antibiotics. Increased values of secreted phospholipase A2 and altered fatty acid metabolism in patients with tonsillitis may have diagnostic utility.
Nasoendoscopy can be used for those with severe neck pain and inability to swallow any fluids to rule out masked epiglottis and supraglotitis. Routine nasoendscopy is not recommended for children.
- pain and fever reducing medications such as paracetamol (acetaminophen) and ibuprofen
- warm salt water gargle, lozenges, honey, or warm liquids
When tonsillitis is caused by a virus, the length of illness depends on which virus is involved. Usually, a complete recovery is made within one week; however, symptoms may last for up to two weeks.
If the tonsillitis is caused by group A streptococcus, then antibiotics are useful, with penicillin or amoxicillin being primary choices. Cephalosporins and macrolides are considered good alternatives to penicillin in the acute setting. A macrolide such as azithromycin or erythromycin is used for people allergic to penicillin. Individuals who fail penicillin therapy may respond to treatment effective against beta-lactamase producing bacteria such as clindamycin or amoxicillin-clavulanate. Aerobic and anaerobic beta lactamase producing bacteria that reside in the tonsillar tissues can "shield" group A streptococcus from penicillins. There is no significant differences in efficacy of various groups of antibiotics in the tonsilitis treatment. Intravenous antibiotics can be for those who are hospitalised with inability to swallow and presented with complications. Oral antibiotics can be resumed immediately if the person is clinically improved and able to swallow orally.
Paracetamol is recommended for the pain treatment. Although nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and opioids such as codeine and tramadol are equally effective, precautions have to be taken because NSAIDs can cause peptic ulcer disease and are bad for kidneys. Opioids can cause respiratory depression for those who are vulnerable. Similarly, in children, paracetamol and NSAIDs can be used except for codeine need to be used with precautions. Anaesthetic mouthwash can also be used for symptomatic relief.
Corticosteroids are helpful in the reduction of pain and improvement of symptoms in 24 to 48 hours. Oral corticosteroids are recommended unless the person is unable to swallow medications.
Chronic cases can be treated with tonsillectomy (the surgical removal of tonsils) as a choice for treatment. Children have had only a modest benefit from tonsillectomy for chronic cases of tonsillitis.
Since the advent of penicillin in the 1940s, a major preoccupation in the treatment of streptococcal tonsillitis has been the prevention of rheumatic fever, and its major effects on the nervous system (Sydenham's chorea) and heart. Recent evidence would suggest that the rheumatogenic strains of group A beta hemolytic strep have become markedly less prevalent and are now only present in small pockets such as in Salt Lake City, USA. This brings into question the rationale for treating tonsillitis as a means of preventing rheumatic fever.
In chronic/recurrent cases (generally defined as seven episodes of tonsillitis in the preceding year, five episodes in each of the preceding two years or three episodes in each of the preceding three years), or in acute cases where the palatine tonsils become so swollen that swallowing is impaired, a tonsillectomy can be performed to remove the tonsils. Patients whose tonsils have been removed are still protected from infection by the rest of their immune system.
In strep throat, very rarely diseases like rheumatic fever or glomerulonephritis can occur. These complications are extremely rare in developed nations but remain a significant problem in poorer nations. Tonsillitis associated with strep throat, if untreated, is hypothesized to lead to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
- "Tonsillitis". PubMed Health. Archived from the original on 7 January 2017. Retrieved 30 September 2016. CS1 maint: discouraged parameter (link)
- Klug, TE; Rusan, M; Fuursted, K; Ovesen, T (August 2016). "Peritonsillar Abscess: Complication of Acute Tonsillitis or Weber's Glands Infection?". Otolaryngology–Head and Neck Surgery. 155 (2): 199–207. doi:10.1177/0194599816639551. PMID 27026737.
- Spinks, A; Glasziou, PP; Del Mar, CB (5 November 2013). "Antibiotics for sore throat". The Cochrane Database of Systematic Reviews. 11 (11): CD000023. doi:10.1002/14651858.CD000023.pub4. PMC 6457983. PMID 24190439.
- Windfuhr, JP; Toepfner, N; Steffen, G; Waldfahrer, F; Berner, R (April 2016). "Clinical practice guideline: tonsillitis I. Diagnostics and nonsurgical management". European Archives of Oto-Rhino-Laryngology. 273 (4): 973–87. doi:10.1007/s00405-015-3872-6. PMC 7087627. PMID 26755048.
- Lang, Florian (2009). Encyclopedia of Molecular Mechanisms of Disease. Springer Science & Business Media. p. 2083. ISBN 9783540671367. Archived from the original on 2016-10-02. CS1 maint: discouraged parameter (link)
- Jones, Roger (2004). Oxford Textbook of Primary Medical Care. Oxford University Press. p. 674. ISBN 9780198567820. Archived from the original on 2016-08-18. CS1 maint: discouraged parameter (link)
- "Tonsillitis". Archived from the original on 25 March 2016. Retrieved 4 August 2016. CS1 maint: discouraged parameter (link)
- Ferri, Fred F. (2015). Ferri's Clinical Advisor 2016: 5 Books in 1. Elsevier Health Sciences. p. PA1646. ISBN 9780323378222. Archived from the original on 2016-10-02. CS1 maint: discouraged parameter (link)
- Windfuhr, JP; Toepfner, N; Steffen, G; Waldfahrer, F; Berner, R (April 2016). "Clinical practice guideline: tonsillitis II. Surgical management". European Archives of Oto-Rhino-Laryngology. 273 (4): 989–1009. doi:10.1007/s00405-016-3904-x. PMID 26882912.
- Tonsillopharyngitis at Merck Manual of Diagnosis and Therapy Professional Edition
- Wetmore RF. (2007). "Tonsils and adenoids". In Bonita F. Stanton; Kliegman, Robert; Nelson, Waldo E.; Behrman, Richard E.; Jenson, Hal B. (eds.). Nelson textbook of pediatrics. Philadelphia: Saunders. ISBN 978-1-4160-2450-7.
- Thuma P. (2001). "Pharyngitis and tonsillitis". In Hoekelman, Robert A. (ed.). Primary pediatric care. St. Louis: Mosby. ISBN 978-0-323-00831-0.
- Simon HB (2005). "Bacterial infections of the upper respiratory tract". In Dale, David (ed.). ACP Medicine, 2006 Edition (Two Volume Set) (Webmd Acp Medicine). WebMD Professional Publishing. ISBN 978-0-9748327-6-0.
- Bird, J.H; Biggs, T.C; King, E.V (23 November 2014). "Controversies in the management of acute tonsillitis: an evidence-based review". Clinical Otolaryngology. 39 (6): 368–374. doi:10.1111/coa.12299. PMC 7162355. PMID 25418818.
- Tonsillitis and Adenoid Infection Archived 2010-02-10 at the Wayback Machine MedicineNet. Retrieved on 2010-01-25
- S. G. Nour; Mafee, Mahmood F.; Valvassori, Galdino E.; Galdino E. Valbasson; Minerva Becker (2005). Imaging of the head and neck. Stuttgart: Thieme. pp. 716. ISBN 978-1-58890-009-8.
- Brook, I.; Foote, P. A. (2006). "Isolation of methicillin resistant Staphylococcus aureus from the surface and core of tonsils in children". Int J Pediatr Otorhinolaryngol. 70 (12): 2099–2102. doi:10.1016/j.ijporl.2006.08.004. PMID 16962178.
- Brook, I. (2005). "The role of anaerobic bacteria in tonsillitis". Int J Pediatr Otorhinolaryngol. 69 (1): 9–19. doi:10.1016/j.ijporl.2004.08.007. PMID 15627441.
- van Kempen MJ, Rijkers GT, Van Cauwenberge PB (May 2000). "The immune response in adenoids and tonsils". Int. Arch. Allergy Immunol. 122 (1): 8–19. doi:10.1159/000024354. PMID 10859465.
- Perry M, Whyte A (September 1998). "Immunology of the tonsils". Immunology Today. 19 (9): 414–21. doi:10.1016/S0167-5699(98)01307-3. PMID 9745205.
- Ezzeddini R, Darabi M, Ghasemi B, Jabbari Moghaddam Y, Jabbari Y, Abdollahi S, et al. (2012). "Circulating phospholipase-A2 activity in obstructive sleep apnea and recurrent tonsillitis". Int J Pediatr Otorhinolaryngol. 76 (4): 471–4. doi:10.1016/j.ijporl.2011.12.026. PMID 22297210.
- MedlinePlus Encyclopedia: Tonsillitis
- Van Cauwenberge P (1976). "[Significance of the fusospirillum complex (Plaut-Vincent angina)]". Acta Otorhinolaryngol Belg (in Dutch). 30 (3): 334–45. PMID 1015288.CS1 maint: unrecognized language (link) — fusospirillum complex (Plaut-Vincent angina) Van Cauwenberge studied the tonsils of 126 patients using direct microscope observation. The results showed that 40% of acute tonsillitis was caused by Vincent's angina and 27% of chronic tonsillitis was caused by Spirochaeta
- Leung AK, Newman R, Kumar A, Davies HD (2006). "Rapid antigen detection testing in diagnosing group A beta-hemolytic streptococcal pharyngitis". Expert Rev Mol Diagn. 6 (5): 761–6. doi:10.1586/14737184.108.40.2061. PMID 17009909.
- Ezzedini R, Darabi M, Ghasemi B, Darabi M, Fayezi S, Moghaddam YJ, et al. (2013). "Tissue fatty acid composition in obstructive sleep apnea and recurrent tonsillitis". Int J Pediatr Otorhinolaryngol. 77 (6): 1008–12. doi:10.1016/j.ijporl.2013.03.033. PMID 23643333.
- Boureau, F.; Pelen, F; Verriere, F; Paliwoda, A; Manfredi, R; Farhan, M; Wall, R; et al. (1999). "Evaluation of Ibuprofen vs Paracetamol Analgesic Activity Using a Sore Throat Pain Model". Clinical Drug Investigation. 17: 1–8. doi:10.2165/00044011-199917010-00001.
- Praskash, T.; et al. (2001). "Koflet lozenges in the Treatment of Sore Throat". The Antiseptic. 98: 124–7.
- Touw-Otten FW, Johansen KS (1992). "Diagnosis, antibiotic treatment and outcome of acute tonsillitis: report of a WHO Regional Office for Europe study in 17 European countries". Fam Pract. 9 (3): 255–62. doi:10.1093/fampra/9.3.255. PMID 1459378.
- Casey JR, Pichichero ME (2004). "Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children". Pediatrics. 113 (4): 866–882. doi:10.1542/peds.113.4.866. PMID 15060239.
- Brook I (2009). "The role of beta-lactamase-producing-bacteria in mixed infections". BMC Infect Dis. 9: 202. doi:10.1186/1471-2334-9-202. PMC 2804585. PMID 20003454.
- Brook I (2007). "Microbiology and principles of antimicrobial therapy for head and neck infections". Infect Dis Clin North Am. 21 (2): 355–91. doi:10.1016/j.idc.2007.03.014. PMID 17561074.
- Paradise JL, Bluestone CD, Bachman RZ, et al. (1984). "Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials". N. Engl. J. Med. 310 (11): 674–83. doi:10.1056/NEJM198403153101102. PMID 6700642.
- Burton, MJ; Glasziou, PP; Chong, LY; Venekamp, RP (19 November 2014). "Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis" (PDF). The Cochrane Database of Systematic Reviews. 11 (11): CD001802. doi:10.1002/14651858.CD001802.pub3. PMID 25407135.
- Shulman ST, Stollerman G, Beall B, Dale JB, Tanz RR (Feb 15, 2006). "Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States". Clin Infect Dis. 42 (4): 441–7. doi:10.1086/499812. PMID 16421785.
- Scottish Intercollegiate Guidelines Network. (January 1999). "6.3 Referral Criteria for Tonsillectomy". Management of Sore Throat and Indications for Tonsillectomy. Scottish Intercollegiate Guidelines Network- Health care Scotland. ISBN 978-1-899893-66-9. Archived from the original on 2006-10-11. Cite uses deprecated parameter
|chapterurl=(help); CS1 maint: discouraged parameter (link) — notes though that these criteria "have been arrived at arbitrarily" from:
Paradise JL, Bluestone CD, Bachman RZ, et al. (1984). "Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials". N. Engl. J. Med. 310 (11): 674–83. doi:10.1056/NEJM198403153101102. PMID 6700642.
- Paradise JL, Bluestone CD, Colborn DK, Bernard BS, Rockette HE, Kurs-Lasky M (2002). "Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children". Pediatrics. 110 (1 Pt 1): 7–15. doi:10.1542/peds.110.1.7. PMID 12093941. — this later study by the same team looked at less severely affected children and concluded "modest benefit conferred by tonsillectomy or adenotonsillectomy in children moderately affected with recurrent throat infection seems not to justify the inherent risks, morbidity, and cost of the operations"
- Wolfensberger M, Mund MT (2004). "[Evidence based indications for tonsillectomy]". Ther Umsch (in German). 61 (5): 325–8. doi:10.1024/0040-59220.127.116.115. PMID 15195718.CS1 maint: unrecognized language (link) — review of literature of the past 25 years concludes "No consensus has yet been reached, however, about the number of annual episodes that justify tonsillectomy"
- Zoch-Zwierz W, Wasilewska A, Biernacka A, et al. (2001). "[The course of post-streptococcal glomerulonephritis depending on methods of treatment for the preceding respiratory tract infection]". Wiad. Lek. (in Polish). 54 (1–2): 56–63. PMID 11344703.CS1 maint: unrecognized language (link)
- Ohlsson, A.; Clark, K (September 28, 2004). "Antibiotics for sore throat to prevent rheumatic fever: Yes or No? How the Cochrane Library can help". CMAJ. 171 (7): 721–3. doi:10.1503/cmaj.1041275. PMC 517851. PMID 15451830. — Canadian Medical Association Journal commentary on Cochrane analysis
- Danchin, MH; Curtis, N; Nolan, TM; Carapetis, JR (2002). "Treatment of sore throat in light of the Cochrane verdict: is the jury still out?". Medical Journal of Australia. 177 (9): 512–5. doi:10.5694/j.1326-5377.2002.tb04925.x. PMID 12405896. Archived from the original on 2008-07-24. CS1 maint: discouraged parameter (link) — Medical Journal of Australia commentary on Cochrane analysis
- Pickering, Larry K., ed. (2006). "Group A streptococcal infections". Red Book: 2006 Report of the Committee on Infectious Diseases (Red Book Report of the Committee on Infectious Diseases). Amer Academy of Pediatrics. ISBN 978-1-58110-194-2.